24-Month Outcomes of Endovascular Baroreflex Amplification With the MobiusHD Device in Heart Failure With Reduced Ejection Fraction
JACC Heart Fail
.
2025 Jan 7:S2213-1779(24)00868-0.
doi: 10.1016/j.jchf.2024.11.005.
Online ahead of print.
Authors
Kerstin Piayda
1
,
Stefan Bertog
2
,
Kolja Sievert
2
,
Horst Sievert
2
,
Tamaz Shaburishvili
3
,
Irakli Gogorishvili
4
,
Martin Rothman
5
,
James L Januzzi Jr
6
,
JoAnn Lindenfeld
7
,
Gregg W Stone
8
Affiliations
1
CardioVascular Center Frankfurt, Frankfurt, Germany; Universitätsklinikum Gießen und Marburg, Gießen, Germany. Electronic address:
[email protected]
.
2
CardioVascular Center Frankfurt, Frankfurt, Germany.
3
Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia.
4
Helsicore Hospital, Tbilisi, Georgia.
5
Vascular Dynamics Inc, Irvine, California, USA.
6
Massachusetts General Hospital, Harvard Medical School, Baim Institute for Clinical Research, Boston, Massachusetts, USA.
7
Vanderbilt University Medical Center, Nashville, Tennessee, USA.
8
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
PMID:
39818666
DOI:
10.1016/j.jchf.2024.11.005
No abstract available
Publication types
Letter